MedPath

Immediate antidepressant response of oral ketamine versus IV ketamine in depressio

Phase 3
Completed
Conditions
Health Condition 1: F322- Major depressive disorder, singleepisode, severe without psychotic features
Registration Number
CTRI/2020/09/027644
Lead Sponsor
Dr P N Suresh Kumar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
61
Inclusion Criteria

1 Failed 2 trial of different antidepressant class of adequate dose and duration.

2 Current depressive episode is of at least 4 weeks duration.

3 Not received ECT at least prior to enrollment.

Exclusion Criteria

1 Other psychiatric disorders.

2 Pregnancy and lactation.

3 Concurrent major life-threatening illness like malignancy, cardiac failure, renal failure etc.

4 Alcohol and substance abuse and smokers.

5 Patients with electrocardiogram abnormality or abnormality on fundoscopy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
change in clinical ratings of depression in Hamilton Depression Rating ScaleTimepoint: Day 0,3,5,7,9,11,13
Secondary Outcome Measures
NameTimeMethod
Changes in Montgomery Asberg Depression rating scale and Clinical Global Impression of severity and ImprovementTimepoint: Day 0,3,5,7,9,11,13 and 1 month
© Copyright 2025. All Rights Reserved by MedPath